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This Month in the Journal
This month in the Journal, Heather McDermid and
Bernice Morrow (p. 1077) review genetic disorders as-
sociated with chromosome 22q11. This region is in-
volved in chromosomal rearrangements that lead to local
altered gene dosage. Depending on the dosage, cat-eye
syndrome, der(22) syndrome, or velocardiofacial syn-
drome/DiGeorge syndrome can result. McDermid and
Morrow give an overview of these syndromes, discuss
the molecular events that cause the 22q11 rearrange-
ments, and outline the candidate genes and mouse mod-
els for the disorders.
Haplotype Analysis of the HLA Region, by Rubio et
al. (p. 1125)
The HLA region has long been known to have an as-
sociation with susceptibility to multiple sclerosis (MS).
However, the high level of linkage disequilibrium (LD)
in the region has hampered progress aimed at dissecting
the region and pinpointing the variation underlying this
association. To get a better handle on the association,
Rubio et al. performed a comprehensive analysis, in a
case-control study, of haplotypes across the HLA region.
Relatives of cases and controls were collected to establish
haplotypes that have little ambiguity. A log-linear model
was used to look at haplotype interaction in the region
and to separate out confounding effects, such as LD.
This allowed the authors to determine that the TNF
locus and other class III genes in the haplotyped class
III region are not associated with MS, except by virtue
of LD with a class II haplotype. Thus, the class III region
has been effectively dissected out of the equation when
one is looking at MS susceptibility. They also found fur-
ther support for previously identified class I and class II
MS-susceptibility haplotypes, and these were associated
with MS, independent of each other. These haplotypes
did not display any higher-order interactions with each
other but, instead, had an additive effect. This careful
study provides another big step along the road to dis-
secting the role that the HLA region plays in MS.
Network Analysis of mtDNA Haplogroups, by
Herrnstadt et al. (p. 1152)
Herrnstadt et al. report on the complete mtDNA coding-
region sequences from 560 unrelated individuals from the
United States and the United Kingdom. Sequences were
analyzed by use of reduced median networks, and, in this
report, the authors focused on haplogroup-specific and
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haplogroup-associated polymorphisms. More than 99%
of the sequences could be unambiguously assigned to a
single haplogroup, and, in general, the sequences confirm
previous haplogroup classifications. In addition, a large
number of polymorphisms are reported for the first time,
allowing the authors to extend our understanding of the
phylogenetic relationships of mtDNA sequences from the
major human ethnic groups. There were a relatively large
number of sites at which homoplasy, or similarity that is
not due to inheritance from a recent common ancestor,
occurred. Homoplasy can complicate phylogenetic anal-
ysis, especially in small samples, but the authors think
that the effects of this homoplasy can be reduced by the
use of the additional haplogroup-specific polymorphisms
that have been discovered in these sequences. Finally, eval-
uation of linkage disequilibrium over distance did not
reveal any consistent evidence of mtDNA recombination.
The mtDNA sequences presented here will be a valuable
resource for many types of mtDNA studies.
CNTF as a Modifier Gene in FALS, by Giess et al. (p.
1277)
Mutations in SOD-1 are found in ∼20% of patients with
familial amyotrophic lateral sclerosis (ALS), but the age
at onset and the duration of disease can be quite dif-
ferent, even within the same family. The basis for some
of this phenotypic variation may be more clear now that
Giess et al. report a mutation that influences the age at
onset of familial ALS. They describe a patient who died
from ALS at age 25 years, after a rapid disease course.
He possessed both a missense mutation in SOD-1 and
a homozygous truncating mutation in CNTF. Other
SOD-1–mutation carriers in the family did not carry the
CNTF mutation in a homozygous state and had either
much later disease onset or no symptoms at the time of
the study (i.e., at age 35 years). Further supporting the
role of CNTF as a modifier of ALS onset is the fact that,
in sporadic cases of ALS, patients who are homozygous
for the CNTF mutation have a significantly earlier age
at onset than do patients with two intact CNTF alleles.
The same is true in a mouse model: mice carrying both
a SOD-1 mutation and a homozygous CNTF mutation
have both an earlier onset of disease and higher rates of
motoneuron loss in the lumbar spinal cord than do mice
that have the SOD-1 mutation but that are wild type
for CNTF. CNTF encodes ciliary neurotrophic factor,
which is a survival factor for motoneurons. CNTF does
not appear to be essential for motoneuron survival dur-
ing development, but it is essential for maintenance of
function in these neurons postnatally. It has been pro-
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posed that CNTF acts in response to neuron injury or
stress, and this may be a possible explanation for its
modifying effect on SOD-1 mutations, which lead to
motoneuron cell death.
RNASEL in Finland, by Ro¨kman et al. (p. 1299)
Recent work by Carpten et al. (see the reference cited
by Ro¨kman et al.) suggested that the RNASEL gene
might be the relevant gene at HPC1, a locus for hered-
itary prostate cancer, on chromosome 1q24-q25. Ro¨k-
man et al. provide the first confirmation of this associ-
ation in an independent population, a sample of Finnish
families with hereditary prostate cancer (HPC). Seven
variants in RNASEL were identified in this sample, in-
cluding the E265X mutation, which was found in an
affected family in the study by Carpten et al. E265X
was present at a higher frequency in the Finnish families
with HPC than in a control sample of blood donors.
This difference was particularly apparent if only families
with four or more affected individuals were considered
and is especially striking because the sample was not
selected for linkage to the HPC1 locus. Not all affected
individuals in E265X-positive families carried the mu-
tation, but the median age at diagnosis for mutation
carriers tended to be earlier than that of affected indi-
viduals who did not carry the mutation. An association
was not found between the RNASEL variants and un-
selected cases of either prostate cancer or benign pro-
static hyperplasia, so, at least in this sample, RNASEL
does not appear, at the population level, to have an im-
pact on prostate cancer. The authors speculate that
RNASEL variants may not be sufficient to cause disease
but that, instead, they may act as modifiers of disease
onset in HPC. RNASEL encodes an RNase that func-
tions in the antiviral and antiproliferative roles of the
interferons, and mice lacking RNase L show suppression
of apoptosis in thymocytes and fibroblasts treated with
apoptotic agents (as described in 1997 by Zhou et al.,
in an article published in The EMBO Journal [vol. 16,
pp. 6355–6363]).
Identification of Human PKHD1, by Onuchic et al.
(p. 1305)
Onuchic et al. report the identification of PKHD1, the
gene responsible for autosomal recessive polycystickidney
disease (ARPKD), a severe and clinically variable disease
that generally presents with enlarged, polycystic kidneys,
pulmonary hypoplasia, and liver involvement. This group
previously had mapped PKHD1 to an 834-kb interval on
chromosome 6p. In the study reported here, they assem-
bled a transcript map of this interval and targeted, for
mutation analysis, transcripts with evidence of kidney ex-
pression. In a large gene with complex splicing patterns,
they report mutations on 21 of 50 ARPKD chromosomes.
Northern blots for the PKHD1 transcript show the high-
est level of expression in the kidney, and, consistent with
the predicted complexity of alternative splicing in this
gene, the transcript appears as a smear rather than as
discrete bands. Missense and frameshift mutations are
spread across the largest open reading frame in PKHD1,
which is predicted to encode an integral membrane pro-
tein that the authors have dubbed “polyductin.” Segments
of polyductin share homology with other known proteins
and domains, but its function is not yet known. Other
splice variants of PKHD1 potentially could encode se-
creted forms of polyductin, but it is not known which
transcripts are actually translated. PKHD1 has also been
identified recently by Ward et al., in an article in Nature
Genetics (vol. 30, pp. 259–269 [2002]). An identical gene
product was predicted in that article, although it was
termed “fibrocystin.”
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